Forte Biosciences, Inc.
FBRXDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Aug 13, 2026
16dMarket Overview
Stock performance and key metrics
2 upcoming, 0 past
How FBRX's past catalysts played out
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Forte Biosciences, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Forte Biosciences, Inc.'s (FBRX) pipeline across Phase 2. Its lead program is FB102 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Forte Biosciences, Inc.'s next FDA catalyst?→
Forte Biosciences, Inc.'s (FBRX) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track FBRX biotech catalysts?→
Add FBRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Forte Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.